Does revascularization improve survival compared to medical therapy in patients with ischemic cardiomyopathy based on the presence of hibernating myocardium?
In patients with ischemic cardiomyopathy, the presence of hibernating myocardium, rather than ischemia, identifies those who may gain a survival benefit from revascularization.
Among patients with ischemic cardiomyopathy, hibernating, but not ischemic, myocardium identifies which patients may accrue a survival benefit with revascularization versus medical therapy.
Ling et al. (2013) studied this question.